Dr. Jakub Tolar will become president and CEO of the nationally renowned Baylor College of Medicine.
Health Care + Med Tech
Thomas Fraser will lead the negotiations with help from Dr. William McGuire and Lois Quam, former UHG executives.
The latest raise marks the second time in over three years the Minneapolis-based startup has netted millions of dollars to continue to expand its healthcare navigation services.
Clearance allows the Maple Grove-based medical device company to take its prostate cancer treatment to the market.
The medical device company credits new growth drivers for improved results.
Minnesota’s A.G. worked with Fairview and the physicians’ group—both ready to make a health care deal.
M Physicians and Fairview reached an agreement on a new framework. The U of M has publicly opposed it.
The 400,000-square-foot Arbor Lakes campus further expands the Massachusetts-based biotech company into Minnesota.
AcQumen Medical left the statewide competition with $100,000.
The company's innovation marks “a groundbreaking step toward lowering infant mortality.”
To answer a growing demand for orthopedics, Fairview is strengthening its ties to Summit.
Negotiations may lack a real deadline, and the parties may still resist needed compromises and recognition of actual bargaining leverage.
A state grant will allow the medical benefits group to deliver non-pharmalogical treatments to underserved areas of the Twin Cities.
The Minneapolis-based medtech company can now market its wearable sensor to hospitals and cancer centers.
The goal of the new prescription-dispensing facility is to free up pharmacists for patient care.
The medical device maker has unveiled plans to spin off its diabetes business unit into its own publicly traded company that would be headquartered in California.
The Chanhassen-based company plans to use the funds on a randomized trial of its “sonodynamic therapy” for glioblastoma, a deadly type of brain cancer.
Former chief executive Stephen Hemsley will replace Witty. The insurer also reportedly faces a Department of Justice investigation.